Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Billing, Anja M ^a   Ben Hamidane, Hisham ^a   Dib, Shaima S ^a   Cotton, Richard J ^a   Bhagwat, Aditya M ^a   Kumar, Pankaj ^a   Hayat, Shahina ^a   Yousri, Noha A ^a   Goswami, Neha ^a   Suhre, Karsten ^a   Rafii, Arash ^a   Graumann, Johannes ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIATION ANTIGEN; TRANSCRIPTOME;

BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION PROFILING; HUMAN; HUMAN EMBRYONIC STEM CELL; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROTEOMICS;

ANTIGENS, DIFFERENTIATION; GENE EXPRESSION PROFILING; HUMAN EMBRYONIC STEM CELLS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; PROTEOMICS; TRANSCRIPTOME;

EID: 84957566879     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21507     Document Type: Article

References (70)

1. Hass, R., Kasper, C., Böhm, S. & Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. doi: 10.1186/1478-811X-9-12 (2011).
2. Le Blanc, K. et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. The Lancet 371, 1579-1586 (2008).
3. Ringdén, O. et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81, 1390-1397 (2006).
4. Sun, L. et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62, 2467-2475 (2010).
5. Tyndall, A. & van Laar, J. M. Stem cells in the treatment of inflammatory arthritis. Best Pract. Res. Clin. Rheumatol. 24, 565-574 (2010).
6. Wang, D. et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res. Ther. 16, R79 (2014).
7. Hare, J. M. et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308, 2369-2379 (2012).
8. Zhang, Z. et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J. Gastroenterol. Hepatol. 27, 112-120 (2012).
9. von Bahr, L. et al. Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation. STEM CELLS 30, 1575-1578 (2012).
10. Prockop, D. J., Kota, D. J., Bazhanov, N. & Reger, R. L. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J. Cell. Mol. Med. 14, 2190-2199 (2010).
11. Uccelli, A. & Prockop, D. J. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr. Opin. Immunol. 22, 768-774 (2010).
12. Friedenstein, A. J., Piatetzky-Shapiro, I. I. & Petrakova, K. V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16, 381-390 (1966).
13. Kern, S., Eichler, H., Stoeve, J., Klüter, H. & Bieback, K. Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue. STEM CELLS 24, 1294-1301 (2006).
14. Pevsner-Fischer, M., Levin, S. & Zipori, D. The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev. 7, 560-568 (2011).
15. Davies, O. G., Cooper, P. R., Shelton, R. M., Smith, A. J. & Scheven, B. A. A comparison of the in vitro mineralisation and dentinogenic potential of mesenchymal stem cells derived from adipose tissue, bone marrow and dental pulp. J. Bone Miner. Metab. 33, 371-382 (2014).
16. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I. & Frolova, G. P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247 (1968).
17. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999).
18. Bianco, P., Robey, P. G. & Simmons, P. J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313-319 (2008).
19. Wagner, W. et al. Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells. PLoS ONE doi: 10.1371/journal.pone.0005846 (2009).
20. Boyd, N. L., Robbins, K. R., Dhara, S. K., West, F. D. & Stice, S. L. Human Embryonic Stem Cell-Derived Mesoderm-like Epithelium Transitions to Mesenchymal Progenitor Cells. Tissue Eng. Part A 15, 1897-1907 (2009).
21. Hematti, P. Human embryonic stem cell-derived mesenchymal stromal cells. Transfusion (Paris) 51, 138S-144S (2011).
22. de Peppo, G. M. et al. Human Embryonic Mesodermal Progenitors Highly Resemble Human Mesenchymal Stem Cells and Display High Potential for Tissue Engineering Applications. Tissue Eng. Part A 16, 2161-2182 (2010).
23. Vodyanik, M. A. et al. A Mesoderm-Derived Precursor for Mesenchymal Stem and Endothelial Cells. Cell Stem Cell 7, 718-729 (2010).
24. Kimbrel, E. A. et al. Mesenchymal Stem Cell Population Derived from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties. Stem Cells Dev. 23, 1611-1624 (2014).
25. Sánchez, L. et al. Enrichment of Human ESC-Derived Multipotent Mesenchymal Stem Cells with Immunosuppressive and Anti- Inflammatory Properties Capable to Protect Against Experimental Inflammatory Bowel Disease. STEM CELLS 29, 251-262 (2011).
26. Hajizadeh-Saffar, E. et al. Inducible VEGF Expression by Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Reduces the Minimal Islet Mass Required to Reverse Diabetes. Sci. Rep. doi: 10.1038/srep09322 (2015).
27. Wang, X. et al. Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis. Stem Cell Rep. 3, 115-130 (2014).
28. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006).
29. Raynaud, C. M. & Rafii, A. The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting. Stem Cells Int. doi: 10.1155/2013/892340 (2013).
30. Trivedi, P. & Hematti, P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp. Hematol. 36, 350-359 (2008).
31. Raynaud, C. M. et al. Human Embryonic Stem Cell Derived Mesenchymal Progenitors Express Cardiac Markers but Do Not Form Contractile Cardiomyocytes. PLoS ONE 8, e54524 (2013).
32. Ong, S.-E. et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics. Mol. Cell. Proteomics 1, 376-386 (2002).
33. Liberski, A. R. et al. Adaptation of a Commonly Used, Chemically Defined Medium for Human Embryonic Stem Cells to Stable Isotope Labeling with Amino Acids in Cell Culture. J. Proteome Res. 12, 3233-3245 (2013).
34. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562-578 (2012).
35. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinforma. Oxf. Engl. 25, 2078-2079 (2009).
36. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
37. DeLuca, D. S. et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 28, 1530-1532 (2012).
38. Wessel, D. & Flügge, U. I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141-143 (1984).
39. Rappsilber, J., Ishihama, Y. & Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663-670 (2003).
40. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
41. Elias, J. E. & Gygi, S. P. Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol. Biol. Clifton NJ 604, 55-71 (2010).
42. Vizcaíno, J. A. et al. The Proteomics Identifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069 (2013).
43. Xie, W. et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 153, 1134-1148 (2013).
44. Miranda, H. C. et al. A quantitative proteomic and transcriptomic comparison of human mesenchymal stem cells from bone marrow and umbilical cord vein. PROTEOMICS 12, 2607-2617 (2012).
45. Roson-Burgo, B., Sanchez-Guijo, F., Del Cañizo, C. & De Las Rivas, J. Transcriptomic portrait of human Mesenchymal Stromal/Stem cells isolated from bone marrow and placenta. BMC Genomics 15, 910 (2014).
46. Tsai, M.-S. et al. Functional Network Analysis of the Transcriptomes of Mesenchymal Stem Cells Derived from Amniotic Fluid, Amniotic Membrane, Cord Blood, and Bone Marrow. STEM CELLS 25, 2511-2523 (2007).
47. Raynaud, C. M. et al. Endothelial cells provide a niche for placental hematopoietic stem/progenitor cell expansion through broad transcriptomic modification. Stem Cell Res. 11, 1074-1090 (2013).
48. Graumann, J. et al. Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Proteome Quantitation of Mouse Embryonic Stem Cells to a Depth of 5,111 Proteins. Mol. Cell. Proteomics 7, 672-683 (2008).
49. Calloni, R., Cordero, E. A. A., Henriques, J. A. P. & Bonatto, D. Reviewing and Updating the Major Molecular Markers for Stem Cells. Stem Cells Dev. 22, 1455-1476 (2013).
50. Aomatsu, E. et al. Novel SCRG1/BST1 axis regulates self-renewal, migration, and osteogenic differentiation potential in mesenchymal stem cells. Sci. Rep. 4, 1-9 (2014).
51. Kim, M.-S. et al. A draft map of the human proteome. Nature 509, 575-581 (2014).
52. Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature 509, 582-587 (2014).
53. Phanstiel, D. H. et al. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat. Methods 8, 821-827 (2011).
54. Rigbolt, K. T. G. et al. System-Wide Temporal Characterization of the Proteome and Phosphoproteome of Human Embryonic Stem Cell Differentiation. Sci. Signal. doi: 10.1126/scisignal.2001570 (2011).
55. Holley, R. J. et al. Comparative Quantification of the Surfaceome of Human Multipotent Mesenchymal Progenitor Cells. Stem Cell Rep. 4, 473-488 (2015).
56. Vaquerizas, J. M., Kummerfeld, S. K., Teichmann, S. A. & Luscombe, N. M. A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 10, 252-263 (2009).
57. Aruga, J. The role of Zic genes in neural development. Mol. Cell. Neurosci. 26, 205-221 (2004).
58. Ganss, B. & Jheon, A. Zinc Finger Transcription Factors in Skeletal Development. Crit. Rev. Oral Biol. Med. 15, 282-297 (2004).
59. Okada, K. et al. Identification of SCAN Domain Zinc-Finger Gene ZNF449 as a Novel Factor of Chondrogenesis. PLoS ONE doi: 10.1371/journal.pone.0115169 (2014).
60. Hasegawa, R. et al. Identification of ZNF395 as a novel modulator of adipogenesis. Exp. Cell Res. 319, 68-76 (2013).
61. Li, Y. et al. ZNF322, a novel human C2H2 Kruppel-like zinc-finger protein, regulates transcriptional activation in MAPK signaling pathways. Biochem. Biophys. Res. Commun. 325, 1383-1392 (2004).
62. Hemmi, K. et al. A Homeodomain-Zinc Finger Protein, ZFHX4, Is Expressed in Neuronal Differentiation Manner and Suppressed in Muscle Differentiation Manner. Biol. Pharm. Bull. 29, 1830-1835 (2006).
63. Brun, J. et al. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b. Bone 53, 6-12 (2013).
64. Kadrmas, J. L. & Beckerle, M. C. The LIM domain: from the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell Biol. 5, 920-931 (2004).
65. Benevento, M. et al. Proteome adaptation in cell reprogramming proceeds via distinct transcriptional networks. Nat. Commun. doi: 10.1038/ncomms6613 (2014).
66. Griffiths, S., Baraniak, P. R., Copland, I. B., Nerem, R. M. & McDevitt, T. C. Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro. Cytotherapy 15, 1469-1483 (2013).
67. Mindaye, S. T., Ra, M., Lo Surdo, J. L., Bauer, S. R. & Alterman, M. A. Global proteomic signature of undifferentiated human bone marrow stromal cells: Evidence for donor-to-donor proteome heterogeneity. Stem Cell Res. 11, 793-805 (2013).
68. Niehage, C. et al. The Cell Surface Proteome of Human Mesenchymal Stromal Cells. PLoS ONE doi: 10.1371/journal.pone.0020399 (2011).
69. Mabuchi, Y. et al. LNGFR+ THY-1 + VCAM-1hi + Cells Reveal Functionally Distinct Subpopulations in Mesenchymal Stem Cells. Stem Cell Rep. 1, 152-165 (2013).
70. Andreu, Z. & Yáñez-Mó, M. Tetraspanins in extracellular vesicle formation and function. Immunother. Vaccines ( doi: 10.3389/ fimmu.2014.00442 2014).